فصلنامه نفس

1-Hollinghurst S, Peters T, Kaur S, Wiles N, Lewis G, Kessler D. Cost-effectiveness of therapistdelivered online cognitive behavioral therapy for depression. British. The British Journal of Psychiatry. 2010;197(4): 297-304.
2-MortonJ, Snowdon S, Gopold M, Guymer, E.Acceptance and Commitment Therapy Group Treatment for Symptoms of Borderline Personality Disorder.A Public Sector Pilot Study. Cognitive and Behavioral Practice.2012;19(4): 527-544.
3-Astals M, Díaz L, Domingo A, SantosA, Bulbena A,Torrens M.Impact of Co-Occurring Psychiatric Disorders on Retention in a Methadone Maintenance Program. Journal Environmental Research and Public Health.2009;6(11): 2822-2832.
4-Roberts RE, Roberts CR, Oxine Y.Comorbidity of substance use disorder and other psychiatric disorder among adolescents.evidence from an epidemiologic survey. Drug and Alcohol Dependence. 2007;88(1): 4- 13.
5-Rohn MCH, Lee M R, Kleuter SB, Schwandt ML, Falk D E, Leggio L. Differences Between Treatment-Seeking and Nontreatment-Seeking Alcohol-Dependent Research Participants. An Exploratory Analysis. Alcoholism: Clinical and Experimental Research.2017;41(2):414–420.
6-American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric AssociationPublishing. 2013;
7-Xu J, Rapp RC,Wang J, Carlson RG.The multidimensional structure‏ ‏of external barriers to substance abuse treatment and its invariance across‏ ‏gender.Ethnicityand age. Subst Abus.2008;29:43–54.‎
8-Bardsley PE, Beckman LJ.The health belief model and entry into alcoholismtreatment. Int J Addict.1988 ; 23 (1):19–28.
9-Finney JW, Moos RH.Entering treatment for alcohol abuse. a stressand copingmodel. Addiction.1995; 90:1223–1240.
10- Andréasson S, Finn SW, Bakshi AS. Barriers to treatment for alcohol dependence: a qualitative study. InAddiction Science & Clinical Practice 2013 Sep (Vol. 8, No. 1, pp. 1-1). BioMed Central.
11-Weisner C. Toward an alcohol treatment entry model: a comparisonof problem drinkers in the general population and in treatment. AlcoholClin Exp Res. 1993; 17:746–752.
12-Weisner C, Matzger H. A prospective study of the factors influencingentry to alcohol and drug treatment. J Behav Health Serv Res. 2002;29:126–137.
13-Le Berre A-P, Vabret F, Cauvin C, Pinon K, Allain P, Pitel A-L, et al. Cognitive barriers to readiness to change in alcoholdependentpatients. Alcohol Clin Exp Res. 2012; 36:1542–1549.
14-Karlsgodt K H, Lukas SE, Elman I. Psychosocial Stress and the Duration of Cocaine Use in Non treatment Seeking Individuals with Cocaine Dependence. The American Journal of Drug and Alcohol Abuse.2003;29(3): 539–551.
15-HigginsC, Smith B H, Matthews K.Comparison of psychiatric comorbidity in treatmentseeking.opioid dependent patients with versus without chronic pain. Addiction. 2019;36(3)112-113.
16-Magidson JF، Liu S-M،Lejuez CW، Blanco C. Comparison of theCourse of Substance Use Disordersamong Individuals With andWithout Generalized Anxiety Disorder in a Nationally representative sample. Journal of Psychiatric Research.2012; 46(5), 659–666
17-Torrens M,Gilchrist G,Domingo-Salvany A. Psychiatric comorbidity in illicitdrug users: substance-induced versus independent disorders. Drug Alcohol Depend. 2011;113(2-3):147-156.
18-Conway KP,Compton W,Stinson FS,,Grant BF. Lifetime comorbidity of DSM-IV mood and anxietydisorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcoholand Related Conditions. J Clin Psychiatry. 2006;67(2):247-257.
19-Pettinati HM,O’Brien CP, Dundon WD. current status of co-occurring mood and substance usedisorders: a new therapeutic Target.Am J Psychiatry. 2013;170(1):23-30.
20-De Alwis D, Lynskey MT, Reiersen AM, Agrawal A. Attention deficit/hyperactivity disorder subtypes ‎and substance use and use disorders in NESARC. Addict Behav. 2014;39(8):1278-1285. ‎
21-Hartz SM, Pato CN,Medeiros H,et al. Comorbidity of severe psychotic disorders with measures ofsubstance use. JAMA Psychiatry. 2014;71(3):248-254.
22-Flórez-Salamanca L, Secades-Villa R, Budney AJ, García-Rodríguez O,Wang S,Blanco C. Probabilityand predictors of cannabis use disorders relapse: Results of the National Epidemiologic Survey onAlcohol and Related Conditions (NESARC).Drug Alcohol Depend. 2013;132(0):127-133.
23-Compton WM,Thomas YF,Stinson FS,Grant BF. Prevalence,correlates,disabilityand comorbidity ofDSM-IV drug abuse and dependence in the United States: results from the national epidemiologicsurvey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566-576.
24-Lubman DI,King JA,Castle DJ. Treating comorbid substance use disorders in schizophrenia. Int RevPsychiatry Abingdon Engl. 2010;22(2):191-201.
25-American Psychiatric Association. Diagnostic and Statistical Manualof Mental Disorders (DSM-5_). American PsychiatricAssociationPublishing. 2013.
26-LyversG,LeggioL,AbenavoliL,GasbarriniG. neurobiochemicaland clinical aspects ofcraving in alcohol addiction: a review. Addictive Behaviors.2005;30(2):1209-1224.
27-RobertsAC,RobbinsTW,WeiskrantzL,editors.The prefrontal cortex: execu.1998;27(3)121-122.
28-Lezak M D, Howieson D, LoringDW. NeuropsychologicalAssessment (fourth Eds). New York: Oxford University Press. 2004.
29-Grant BF,Saha T.D, Ruan, WJ, Goldstein RB, Chou S.P, Jung J,et al.Epidemiology of DSM-5 drug use disorder: results fromthe National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry. 2016;73 (1), 39e47.
30- Koudys JW, Ruocco AC. A neurocognitive model of the comorbidity of substance use and personality disorders. InCognition and Addiction 2020 Jan 1 (pp. 79-89). Academic Press.
‎31-Strauss E, Sherman, EMS, Spreen, OA,. Compendium of‏ ‏Neuropsychological ‎Tests: Administration, Norms and Commentary.USA: Oxford‏ ‏University Press.‎ 2006.
‎32-Heaton, RK, Chelune GJ, Talley, J L, Kay, GG, Curtiss, G. Wisconsin card ‎sorting test manual: Revised and expanded. Lutz, FL: Psychological Assessment Resources‏.‏1993.
‎33-Spreen, O, Strauss, EA,.Compendium of neuropsychological tests: ‎Administration, norms, an commentary. New York: Oxford University Press.1991.
‎‎34-Naderi, N,. Evaluation of information processing and some ‎neuropsychological ‎functions of patients with obsessive-compulsive disorder. ‎Master Thesis in Clinical ‎Psychology, Tehran Institute of Psychiatry.‎ 1996.[In Persian]
35-Lundqvist T. Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology Biochemistry and Behavior.2005; 81(2), 319–330.